Description of program
Hypertension is a modifiable risk factor for stroke, myocardial infarction, heart failure, peripheral vascular disease, aortic dissection, atrial fibrillation, and end-stage kidney disease. The asymptomatic characteristic of hypertension can delay diagnosis and treatment. As the increasing risk of obesity and aging of the population, the incidence and prevalence of hypertension also rises. Effective management of hypertension requires an interprofessional and coordinated patient care approach. The program was designed utilizing the latest clinical guidelines and test plans for the certification examinations.
Information about the Cardiac-vascular nursing certification exam by the American Nurses Credentialing Center can be obtained at www.nursecredentialing.org.
Who Should Enroll in this Program?
The program is designed for English-speaking nurses, pharmacists, physical and respiratory therapists, physicians, educators, and other health care providers interested in gaining knowledge pertaining to the management of the disease of hypertension.
The content is divided into modules. Each module utilizes instructor outlines, audio/video recordings, reading assignments, articles, web resources, case studies to augment the learning process. These methods provide the participant with flexibility in completing assignments and interacting with the faculty. Each module has accompanying study guide(s) with questions (such as multiple choice, essay) for participants to submit to faculty. Interaction with faculty may occur as feedback to study guides, within discussion boards, or via email. The modules cover normal physiology, pathophysiology of systemic circulation, patient assessment, diagnostic tests, pharmacology, patient education, and patient management with considerations of age, gender, race/ethnicity.
A textbook is required for this program. Upon registration, you will receive detailed information to purchase the textbook.
This seven-week activity is offered two times a year.
|Feb. 13||March 31|
|July 24||Sept. 8|
|Feb. 12||March 30|
|July 23||Sept. 7|
The learning outcome of this activity is to enable the learner to successfully manage patients whether at primary prevention or diagnosed with hypertension based on current therapeutic guidelines and best practice.
At the conclusion of the program the participant will be able to:
Delivery of Content
The content is delivered asynchronous via the online learning management system, Blackboard. The internet provides an opportunity for interaction with program faculty while in the comfort of learning in your own home and office. Program staff are available during business hours by phone or email to assist participants with technical issues or concerns.
Note: Many businesses, especially government agencies or health institutions, utilize security firewalls. Access to web links within program and communication from the instructor, or other students may be blocked. We recommend not using your work email address for this course.
40 contact hours (8 hours specific to Pharmacotherapeutics)
The program content meets the pharmacology continuing education requirements for the renewal of the advanced practice nurse prescriptive authority license. Nurses will receive 40 total contact hours of which 8 hours are specific to Pharmacology.
Pharmacists will receive 40 contact hours for completion of this program. The Pharmacists Education Foundation is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education. ACPE accreditation #120-999-07-201-H01-P.
Successful completion of this program does not guarantee expertise in the content. Clinical experience and judgment coupled with an understanding of the content are necessary to attain competency. Achieving certification is a means to demonstrate competency.
Criteria for Successful Completion
The certificates will be sent via email within approximately 30 days following the completion of the program.
Faculty Name and Credentials
We strive to provide interprofessional education by utilizing a variety of content experts, instructors, contributors, and reviewers.
Edith Hoehn, BSN, RN, CVN
M. Jane Swartz, DNP, RN, ACNS-BC
Conflict of Interest Statement
There is no conflict of interest for anyone in a position to control content for this activity.
Accreditation with Distinction
The University of Southern Indiana College of Nursing and Health Professions is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. USI was recognized as accredited with distinction through November 30, 2018.
State of California
The University of Southern Indiana is approved by the California Board of Registered Nursing. Provider #13378.
Accreditation Council for Pharmacy Education
The University of Southern Indiana (USI) School of Nursing and Health Professions works closely with the Indiana Pharmacists Alliance to offer several online continuing pharmacy education (CPE) programs. The Indiana Pharmacists Alliance (IPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Refer to the course descriptions to determine if the course includes CPE and review the requirements.
To Register: Click on the link above
The deadline for registration is the Monday prior to the start date by 8 a.m. CDT.
We reserve the right to cancel any offering if there is insufficient enrollment. Registered participants will be notified in advance if this occurs.
For more schedule information, call toll free 1-877-USI-HLTH (874-4584) or 812-461-5217 or email firstname.lastname@example.org.
The fee includes access to the program, along with all resources and handouts. A text, if applicable, is not included in the fee.
There is an additional $80.00 charge for pharmacists requesting contact hours. NOTE: CEs must be requested during registration.
A $25 administrative fee will be charged prior to the start date of the activity if the registration fee has been paid. On or after the start date of the class there will be no refund.